ONE Bio Corp. (ONBI.OB) Names Feng Yu as General Manager, Leveraged by Diverse Experience

QualityStocks would like to highlight ONE Bio Corp. (OTCBB: ONBI). ONE Bio, headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region.

In the company’s news yesterday,

ONE Bio Corp. announced the appointment of Feng Yu, a senior sales executive and expert pharmacist, as general manager for its chemical and herbal extract division.

Yu’s resume includes several senior positions in the pharmaceutical and nutraceutical fields including deputy general manager for Guangdong Oriental Son Pharmacy Co. Ltd., where he was responsible for R&D, production management and sales operation for the medicine and health products; CEO for Guangdong Qingyuan Shengzhitang Modern Traditional Chinese Medicine Co. Ltd., where he was in charge of the company’s operation; and project manager and secretary for League Committee in Pharma Innovation Center of Guangdong Qingyuan Medicine Group, where he was responsible for new product development and submissions.

“We are very pleased to have Mr. Yu join us. Mr. Yu’s extensive experience in R&D for health products, quality control processes and marketing will serve us well as we continue to expand our product portfolio. Since his arrival we have already seen great strategies, initiatives and results from his execution and leadership,” Min Zhao, ONE Bio president (China) stated in the press release.

Yu’s sales experience leveraged him to successfully lead his team twice in passing the National GMP Authentication; he also played a role in the development and implementation of several national and provincial science and technology projects in China.

ONE Bio said it expects Yu’s experience and knowledge to contribute to the company’s efforts and growth in Asia.

“Mr. Yu’s addition to our team strengthens our management group in Asia,” stated ONE Bio CEO Marius Silvasan. “Mr. Yu’s strong operational experience combined to his know-how in the pharmaceutical and nutraceutical fields are key components towards ensuring that as we continue to experience organic growth adequate controls are implemented and enforced to maintain our operational efficiency,” added Silvasan.

Yu graduated from the Department of Biological Pharmacy of China Pharmaceutical University in 2000 and acquired a Qualification Certificate as a National Licensed Pharmacist in 2002.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.